On February 19, 2025, we held the 12th lunchtime Tips "The Frontline of Immunotherapeutic Treatment for Sugi Phymbolosis" at the Communication Lounge of Mitsui Link Lab Shinkiba 2. Masatsuyo Doi, Director of Innovation Research, Torii Pharmaceutical Co., Ltd., Tenant of Mitsui Link Lab Kasai Tenant. As the first time in the Frontier Science series, he talked about epidemiological data, molecular mechanisms, treatment systems, the positioning of immunotherapy, and the future development of cedar pollinosis, which is now called national disease. It was a topic of great interest, so after the lecture, lively exchange of opinions with other tenants continued. We will continue to provide topics related to frontier science by tenants and external parties.
2025.03.04
The 12th Lunchtime Tips "The Frontline of Immunotherapeutic Treatment for Cedar Phymbolism" was held.
